Game Plan Financial Advisors’s IGC Pharma IGC Stock Holding History

Game Plan Financial Advisors’s Portfolio IGC Stock Details IGC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-500	Closed	-$140	–	441
2023 Q4	$140	Buy	+500	New	+$155	﹤0.01%	426

Other funds holding IGC

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dearborn Partners Chicago, Illinois $1.85B AUM 6.59% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return

Truist Financial Charlotte, North Carolina $74.2B AUM 21.09% 1-Year Est. Return

Game Plan Financial Advisors's IGC Position: Q1 2024 in Review

Game Plan Financial Advisors sold out of IGC Pharma (IGC) in Q1 2024, closing a stake of 500 shares — an estimated $140 sold.

Game Plan Financial Advisors first reported a position in IGC in Q4 2023 and held it in 1 quarter. The position peaked at $140 in Q4 2023. 25 funds tracked by Wall St. Rank hold IGC as of Q1 2024.

Game Plan Financial Advisors reported no remaining IGC Pharma position as of Q1 2024 after selling out during the quarter.
Game Plan Financial Advisors sold 500 IGC Pharma shares in Q1 2024, an estimated $140.
Game Plan Financial Advisors first reported a position in IGC Pharma in Q4 2023 and held it in 1 quarter.
Game Plan Financial Advisors's IGC Pharma position peaked at $140 in Q4 2023.
25 funds tracked by Wall St. Rank held IGC Pharma as of Q1 2024.

Based on Game Plan Financial Advisors's 13F filing for Q1 2024, filed 12 Apr 2024.